This one is NGL-2026-Q0FP2X
Not recommended for patients with known hypersensitivity to Vitamin B12 derivatives
5-Amino-1MQ has been discussed in scientific literature involving NNMT research, metabolic pathway analysis, enzyme activity studies, cellular biology, biochemical signaling, and analytical compound characterization
Adverse Effects and Reporting Adverse events or suspected contamination issues should be reported immediately to the manufacturer (Hospira/Pfizer) and relevant regulatory authorities (FDA MedWatch, poison control, or institutional pharmacovigilance systems)
The drug contains three active ingredients simultaneously: Hydroxycobalamin, a metabolite of cyanocobalamin
Intramuscular B12 injections, rather than oral B12 supplements, help correct the deficiency